Roivant Sciences Ltd.
ROIV
주식 순위
#981
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
주가
$33.73
마지막 동기화: 2026-07-31
시가총액
$24.37B
변동 (1일)
-2.28%
변동 (1년)
95.44%
국가
GB
거래 Roivant Sciences Ltd. (ROIV)
카테고리
Healthcare
Roivant Sciences Ltd. (ROIV)의 EPS
June 2026 기준 EPS TTM: $-0.38
Roivant Sciences Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.38입니다. 2024년 말에는 회사의 EPS가 $5.55였으며, 이는 2023년의 EPS $-1.42와 증가입니다.
Roivant Sciences Ltd.의 EPS 기록 (2020 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $-0.38 | 58.33% |
| 2025 | $-0.24 | -104.32% |
| 2024 | $5.55 | -490.85% |
| 2023 | $-1.42 | 12.70% |
| 2022 | $-1.26 | 6.78% |
| 2021 | $-1.18 | -167.43% |
| 2020 | $1.75 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $17.32 | -4,657.89% |
US
|
|
| $-7.98 | 2,000.00% |
US
|
|
| $-5.29 | 1,292.11% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -7,400.00% |
NL
|
